1-(4-(5-Bromopyridin-2-yl)piperazin-1-yl)ethanone

Catalog No. :
ACLZOA259
CAS No. :
494771-76-5
Molecular Formula :
C11H14BrN3O
Molecular Weight :
284.16

IUPAC Name:1-(4-(5-bromopyridin-2-yl)piperazin-1-yl)ethan-1-one

1-(4-(5-Bromopyridin-2-yl)piperazin-1-yl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$58.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(5-Bromopyridin-2-yl)piperazin-1-yl)ethanone
IUPAC Name1-(4-(5-bromopyridin-2-yl)piperazin-1-yl)ethan-1-one
MDL No.MFCD11954763
Molecular FormulaC11H14BrN3O
Molecular Weight284.16
SMILESCC(N1CCN(C2=NC=C(Br)C=C2)CC1)=O
InChI KeyQHIUYPWBDOIIAF-UHFFFAOYSA-N
Synonym494771-76-5 | 1-(4-(5-Bromopyridin-2-yl)piperazin-1-yl)ethanone | 2-(4-Acetylpiperazino)-5-bromopyridine | 1-[4-(5-bromopyridin-2-yl)piperazin-1-yl]ethanone | 1-[4-(5-Bromo-2-pyridinyl)-1-piperazinyl]ethanone | 1-[4-(5-Bromopyridin-2-yl)piperazin-1-yl]ethan-1-one | S
CAS No.494771-76-5
PubChem CID21914468

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P264-P302+P352-P304+P340-P305+P351+P338-P332+P313-P337+P313

Synthetic Route by SureRoute

1. ACLZOA259 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKWO017 route compound structure diagram
    ACCKWO017624-28-2 In Stock
  2. Plus
  3. ACBNDG182 route compound structure diagram
    ACBNDG18213889-98-0 In Stock
  4. Then
  5. ACLZOA259 route product structure diagram
    ACLZOA259494771-76-5 In Stock
Inquiry

2. ACLZOA259 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLZOA259 route product structure diagram
    ACLZOA259494771-76-5 In Stock
Inquiry

Comments (0)